Crispr Therapeutics Price Target Announced at $160.00/Share by JMP Securities
Crispr Therapeutics Price Target Announced at $160.00/Share by JMP Securities
DJ Crispr Therapeutics Initiated at Outperform by JMP Securities
Ratings actions from Benzinga: https://www.benzinga.com/stock/CRSP/ratings
(END) Dow Jones Newswires
March 04, 2021 08:16 ET (13:16 GMT)
DJ Crispr Therapeutics Price Target Announced at $160.00/Share by JMP Securities
Ratings actions from Benzinga: https://www.benzinga.com/stock/CRSP/ratings
(END) Dow Jones Newswires
March 04, 2021 08:16 ET (13:16 GMT)
DJ Crispr Therapeutics Initiated at Outperform by JMP Securities
由JMP證券發起的DJ Crispr治療公司強於大盤
Ratings actions from Benzinga: https://www.benzinga.com/stock/CRSP/ratings
來自本辛加的評級行動:https://www.benzinga.com/stock/CRSP/ratings
(END) Dow Jones Newswires
(完)道瓊通訊社
March 04, 2021 08:16 ET (13:16 GMT)
2021年3月4日08:16美國東部時間(格林尼治標準時間13:16)
DJ Crispr Therapeutics Price Target Announced at $160.00/Share by JMP Securities
JMP證券宣佈DJ Crispr治療公司每股160.00美元的目標價
Ratings actions from Benzinga: https://www.benzinga.com/stock/CRSP/ratings
來自本辛加的評級行動:https://www.benzinga.com/stock/CRSP/ratings
(END) Dow Jones Newswires
(完)道瓊通訊社
March 04, 2021 08:16 ET (13:16 GMT)
2021年3月4日08:16美國東部時間(格林尼治標準時間13:16)
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧